The engine driving healthcare real estate deals in America’s largest markets isn’t just the sheer weight of population—it’s the intersection of demographics, facility distribution, and competitive regional fundamentals. Recent data from Brown Gibbons Lang & Company’s 2025 mid-year market update points to a nuanced landscape where not only do major metros like New York and Los Angeles attract outsized transaction activity, but secondary characteristics such as doctor density and aging populations are reshaping how and where medical office investments are made.
While it’s true that deal activity concentrates in the most populous markets, the report reveals that not all urban centers operate on equal footing. For example, Houston boasts the highest ratio of medical office space per person among top metros at 6.4 square feet, reflecting strategic buildout to accommodate both its sprawling healthcare network and demographic realities. In New York, an extensive network of 1,756 medical office buildings serves a population approaching 20 million, and Los Angeles, with 1,301 facilities and more than 60 million square feet, illustrates how infrastructure scales alongside provider counts.
Compelling regional differences in deal flow also emerge. The Southeast led the nation in year-to-date transaction volume, surpassing $1.2 billion across 194 properties and 4.5 million square feet, with the Mid-Atlantic and South Central trailing but still posting healthy figures. Meanwhile, New England and the Southwest reported less than $500 million in volume each, exposing how market momentum varies sharply by region and local market conditions. Here, investor attention is directed not just at raw population or facility count, but at underlying metrics such as physician density and the percentage of individuals over age 65, which Miami demonstrates with 0.81 doctors per hundred residents, far above the top 100 metro average.
What distinguishes this investment cycle is how capital is chasing medical office assets that serve the intricate needs of evolving urban demographics. Miami’s elevated physician presence, Houston’s abundant square footage per person, and the substantial inventories in New York and Los Angeles all point to a market where investors and developers must interpret granular data—not just aggregate population—to anticipate demand and optimize their real estate strategies. These findings suggest that while density may set the table for robust deal activity, it’s the details beneath the surface—provider counts, facility distribution, and demographic shifts—that increasingly determine who leads and who lags in healthcare real estate investment.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.